Razelle Kurzrock, Founding Director at Michels Rare Cancers Research Laboratories, shared a paper she and her colleagues authored on X:
“CUP: it’s all about knowing the unknown. The key is the underlying molecular drivers and maximizing biomarker matching.”
Title: Multi-omic analysis in carcinoma of unknown primary (CUP): therapeutic impact of knowing the unknown
Authors: Shumei Kato, Sophia Gumas, Jacob J. Adashek, Ryosuke Okamura, Suzanna Lee, Jason K. Sicklick, Razelle Kurzrock
Read The Full Article
Other articles featuring Carcinoma on OncoDaily.
